<DOC>
	<DOCNO>NCT00475852</DOCNO>
	<brief_summary>The purpose study find nesiritide ( human B-type natriuretic peptide/hBNP ) compare placebo , plus usual treatment acute decompensated heart failure , help improve breathing difficulty , reduce heart failure readmission hospital , help patient live long .</brief_summary>
	<brief_title>A Study Testing Effectiveness Nesiritide Patients With Acute Decompensated Heart Failure</brief_title>
	<detailed_description>Acute Decompensated Heart Failure ( ADHF ) inability heart pump efficiently , result symptom like shortness breath rest minimal activity . ADHF condition heart perform necessary circulation blood body . This randomize ( study medication assign chance ) , double-blind ( neither patient doctor know whether patient assign receive study drug placebo [ contain study drug ] ) , placebo-controlled , parallel group , multicenter study effectiveness nesiritide administer continuously vein minimum 24 hour maximum 7 day . The study hypothesis nesiritide give addition standard care superior placebo give addition standard care measure relief breathe difficulty ( patient evaluation utilize breathlessness scale ) 6 hour 24 hour nesiritide administration , reduction rehospitalization due heart failure death study drug administration Day 30 . The study drug ( nesiritide ) placebo dose study 0.010 mcg/kg/min without 2 mcg/kg initial bolus ( one time injection ) nesiritide . Patient safety monitor throughout study physical exam , vital sign ( heart rate , blood pressure , respiratory rate , temperature ) , blood test , side effect . The patient assign nesiritide group receive continuous intravenous ( vein ) infusion 0.010 mcg/kg/min nesiritide without 2 mcg/kg bolus ( one time injection ) . The patient assign placebo group receive match placebo bolus infusion . The bolus give one minute continuous infusion give least 24 hour 7 day .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Hospitalized management acute decompensated heart failure ( ADHF ) diagnose ADHF within 48 hour hospitalize another reason ; Diagnosis ADHF define dyspnea ( difficulty breathe ) rest dyspnea minimal activity . At high risk hypotension ( low blood pressure ) ; Acute coronary syndrome primary diagnosis ; History cardiac valvular stenosis , restrictive cardiomyopathy , hypertrophic cardiomyopathy , pericardial tamponade ; Previous enrollment nesiritide study ; Persistent , uncontrolled hypertension ( SBP [ systolic blood pressure ] &gt; 180 mmHg ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Heart Decompensation</keyword>
	<keyword>Dyspnea</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Nesiritide</keyword>
	<keyword>Decompensated</keyword>
	<keyword>ADHF</keyword>
</DOC>